supported by the Significant New Drugs Development Science and Technology Major Projects of China(2010ZX09401-407);State-level Public Welfare Scientific Research Institutes for Basic R&D Special Fund(IMBF201101)
The main goal of this study was to investigate whether lidamycin (LDM) could enhance the efficacy of paclitaxel (TAX) against breast cancer. In the MTT assay, LDM showed much more potent cytotoxicity than paclitaxel, ...